Recently, the complete amino acid sequence of a protein expressed in Escherichia coli from cloned Brucella abortus DNA was reported. On the basis of amino acid homology, this protein was identified as a copper-zinc superoxide dismutase (Cu-Zn SOD) (B. L. Beck, L. B. Tabatabai, and J. E. Mayfield, Biochemistry 29:372-376, 1990). We demonstrate in this paper that the sequenced protein is the same as the previously studied salt-extractable protein BCSP20. The plasmid-encoded protein expressed from recombinant E. coli is identical to the Brucella-derived BCSP20 in molecular mass, N-terminal amino acid sequence, and crossreactivity with homologous and heterologous rabbit sera against either the recombinant gene product or the Brucella-derived protein. A survey of the expression of the Cu-Zn SOD protein in Brucella biovars representing all species was done by Western blotting (immunoblotting) using antisera raised against the recombinant E. coli-derived protein. With the exception of B. neotomae and B. suis biovar 2, the Cu-Zn SOD protein was detectable in all Brucella species and biovars tested, including eight biovars of B. abortus.
Brucella abortus S19 salt-extractable protein (BCSP) mixture contains a group of antigenic or periplasmic proteins which we have been investigating for their potential value as vaccine and diagnostic reagents for the prevention and diagnosis of brucellosis (10) (11) (12) (13) . One protein with an apparent size of 20 kilodaltons (kDa) (12) was originally described as BCSP20. It is reported here that this protein is the same as the previously reported Brucella copper-zinc superoxide dismutase (Cu-Zn SOD, EC 1.15.1.1) cloned into Escherichia coli (1) . While Cu-Zn SOD is commonly found in eucaryotes, it is rarely found in bacteria (9) and has not been reported for E. coli. This paper describes the cloning and expression of the Brucella Cu-Zn SOD gene in E. coli, purification of the encoded protein, and evidence that the recombinant E. coli-derived Cu-Zn SOD and the Brucella-derived BCSP20 are the same protein. We also examined Brucella species and representative biovars for the occurrence of the Cu-Zn SOD protein by Western blot (immunoblot).
MATERIALS AND METHODS Bacterial growth conditions. E. coli strains were cultured in Luria broth; those containing plasmids were incubated with 25 jig of ampicillin per ml (7) . The bacteria were incubated overnight at 37°C in a gyratory shaker at 260 rpm.
Brucella spp. were cultured as previously described (13) .
Briefly, bacteria were cultured on tryptose-serum agar (B. abortus biovar 2 and B. ovis) or on potato infusion agar. B. abortus strains (except S19 and 2308) and B. ovis were grown in the presence of 5% CO2. Cloning of the Cu-Zn SOD gene. A B. abortus genomic library was constructed as previously described (8) . Lambda bacteriophage plaques were screened with rabbit sera raised against BCSP. Lysates from positive plaques were separated by SDS-PAGE and screened by Western blotting by using the same anti-BCSP extract antiserum used to screen plaques. Lambda DNA from one of the recombinant lambda clones expressing a 20-kDa protein was cleaved with EcoRI, and the resultant fragments were cloned into the multiple cloning site of pUC9. The plasmids were transformed into E. coli 71/18 (16) . Two plasmids with DNA inserts in opposite orientations were designated pBA20-B3 and pBA20-B12.
Bacterial colonies were screened for expression of the desired antigen, as previously described (8) , with antisera raised against BCSP. Plasmid DNA was isolated by the method of Birnboim and Doly (2), followed by a phenol extraction step.
Extraction of Brucella Cu-Zn SOD from E. coli. Overnight cultures of E. coli 71/18(pBA20-B12) (100 ml to 1.5 liters) were pelleted at 3,000 x g for 15 min. The pellet was weighed, and extraction buffer (10 mM phosphate buffer, pH 7.5, containing 0.1% Triton X-100) was added at 2 ml/g of packed E. coli (3). The pellet was swirled to suspend the bacteria and shaken overnight (260 rpm on a gyratory shaker at 37°C).
After 16 SDS-PAGE. The SDS-PAGE system used was based on the method of Laemmli (6), by using slab gels (12.5 by 14 cm) consisting of a 4.5% stacking gel (pH 6.8) and a 12% running gel (pH 8.6). Electrophoresis was performed overnight at 60 V. Gels were stained with Coomassie blue R-250 (Bio-Rad Laboratories, Richmond, Calif.) by the method of Weber and Osborn (15) .
Alternatively, samples were separated on 10 to 15% acrylamide gradient gels (Pharmacia) by using the Pharmacia PhastGel system. These gels were also stained with Coomassie blue R-250 according to the recommendations of the manufacturer.
Antisera. Antisera were obtained from rabbits that had been injected with 100 pLg of purified Brucella-derived BCSP20, recombinant E. coli-derived Brucella Cu-Zn SOD, or partially purified BCSP extract, as previously described (11) . The antigens were emulsified with complete Freund adjuvant (Difco Laboratories, Detroit, Mich.) and injected subcutaneously at multiple sites. Subsequent injections were prepared with incomplete Freund adjuvant and were given intramuscularly once a week for 3 weeks.
When recombinant E. coli-derived Brucella Cu-Zn SOD preparations were screened with antisera, anti-E. coli antibodies were removed as follows: 1.5 g of packed E. coli (lacking plasmid) from an overnight culture was suspended in 15 ml of lysis buffer (4.0% Triton X-100, 5 mM EDTA). After a 1-h incubation at 25°C, the lysate was passed five times through a 26-gauge syringe needle to reduce viscosity and then mixed 1:10 (vol/vol) with diluted serum. The mixture was incubated for 2 h at 25°C with agitation. The lysate debris was not removed from the serum before use.
Western blotting. Electrotransfer to nitrocellulose sheets was performed by the method of Towbin et al. (14) . Antigenbound nitrocellulose filter paper was treated with blocking solution containing 3% bovine serum albumin in TBS (20 mM Tris, 500 mM NaCl [pH 7.5]) prior to the addition of primary antiserum (rabbit antiserum diluted 1:200 prepared with TBS containing 0.3% bovine serum albumin and 0.01% merthiolate). The filter was incubated with agitation for 2 h at 37°C or overnight at 4°C. The blot was washed five times in TBS with 0.05% Tween 20 for a total of 25 min and incubated with horseradish peroxidase-conjugated goat antirabbit antibody (heavy chain specific) (Cappel, Organon Teknika, West Chester, Pa.) diluted 1:200. The blot was washed as described above except that the final wash was in Restriction map of pBA20-B12, pBA20-B3, and pBA20-1527. pBA20-1527 was derived from pBA20-B3 in two steps. First, the plasmid was cut with PstI and religated; then, the plasmid was cut with HindlIl and the 2.3-kb fragment was recloned into pUC9. C, ClaI; H, HindlIl; P, PstI; R, EcoRI. The numbers below each map refer to the kilobase sizes of the fragments.
TBS. The filter was developed in a solution of TBS containing 0.06% 4-chloro-1-naphthol as the chromogen, 0.012% hydrogen peroxide, and 20% ethanol.
RESULTS
Cloning of the Brucella Cu-Zn SOD gene. Screening of the B. abortus S19 genomic library with rabbit anti-BCSP antiserum resulted in identification of numerous plaques expressing Brucella proteins. A plaque which produced a 20-kDa protein was selected for cloning into the plasmid pUC9 at the EcoRI cloning site.
Subcloned plasmids positive for BCSP, as detected with rabbit anti-BCSP antiserum, contained an 11.1-kilobase (kb) EcoRI insert. A restriction map of this insert is shown in Fig.  1 . Two plasmids with opposite orientations were designated pBA20-B3 and pBA20-B12 (Fig. 1) .
A 2.3-kb fragment was subcloned in two steps. This plasmid was designated pBA20-1527. There was no detectable difference in the expression of the gene products from pBA20-B3, pBA20-B12, or subclone pBA20-1527 on the basis of Western blotting, and all three plasmids were used in subsequent work.
Purification of the recombinant E. coli-derived Brucella protein. Enrichment of the E. coli-derived Brucella protein by detergent extraction of an overnight culture of E. coli 71/18(pBA20-B12) is shown in Fig. 2 , lanes B and C. Chromatographically purified protein is shown in lane D. The protein has an apparent molecular mass of 16 to 17 kDa under nonreducing conditions and 20 kDa when reduced with 2-mercaptoethanol (2-ME) prior to electrophoresis (see below). Figure 3 shows the chromatographic profile of the protein extract derived from recombinant E. coli. The 20-kDa gene product eluted as a sharp peak at 95 to 110 mM NaCl. Fractions containing the desired protein were pooled as determined by A230 and immunological detection by dot blot. The resulting preparation was free of detectable contaminants (Fig. 2, lane D) . As much as 45 mg of the purified protein could be obtained from a 1,500-ml overnight culture of recombinant E. coli (10.6 g [wet weight] of packed E. coli). The recombinant E. coli-derived protein, purified as described here, followed by SDS-PAGE and electroelution, was subsequently used for amino acid sequencing resulting in the identification of the protein as Cu-Zn SOD (1). Comparison of Brucella-derived BCSP20 and recombinant E. coli-derived Cu-Zn SOD. (i) Molecular mass. The proteins derived from both E. coli 71/18(pBA20-B12) and B. abortus S19 migrated with an apparent molecular mass of 20 kDa when chemically reduced with 2-ME immediately prior to electrophoresis (Fig. 4, lanes A and B) , in contrast to an apparent molecular mass of 16 to 17 kDa under nonreducing conditions (Fig. 2, lane D) . When purified recombinant E. coli-derived Brucella Cu-Zn SOD protein was electrophoresed under nonreducing conditions, additional bands appeared with apparent molecular masses of 30, 54, and 75 kDa (Fig. 4, lane C) .
(ii) Immunologic cross-reactivity. Antigenic similarity between the Brucella-derived and E. coli-derived proteins was established by Western blot analysis (Fig. 4, lanes A respectively) by using antiserum raised against the E. coliderived protein. Conversely, antiserum raised against the Brucella-derived BCSP20 also recognized both proteins (data not shown).
(iii) Amino acid sequence. The N-terminal amino acid sequence of the first 40 residues of the Brucella-derived BCSP20 was identical to the previously published amino acid sequence of the recombinant E. coli-derived Cu-Zn SOD (data not shown).
Expression of the Cu-Zn SOD protein in the genus Brucella. Thirty-four Brucella strains, including all six of the known species, were examined for expression of Cu-Zn SOD on the basis of antigenic recognition (Table 1 ). Figure 5 shows Western blots of the total cell protein from each strain screened with rabbit antiserum against the recombinant E. coli-derived Cu-Zn SOD. Use of antisera raised against recombinant Cu-Zn SOD protein isolated from E. coli avoids cross-reactivity with other Brucella proteins or cell components.
The Cu-Zn SOD protein was present in most of the Brucella strains and species examined (Fig. 5) . Antigenically recognizable Cu-Zn SOD was undetectable in B. suis biovar 2 and B. neotomae (Fig. 5, lanes 17 and 29, respectively) .
For all other species and biovars, a protein of the same size was recognized by the antiserum. Two cross-reactive polypeptides also occurred in Yersinia enterocolitica (Fig. 5, lane  35 ).
DISCUSSION
It was previously shown that B. abortus contains Cu-Zn SOD protein (1) and also that an antigenic protein with an apparent molecular weight of 20,000 (previously referred to as BCSP20) could be extracted, along with several other cell surface and periplasmic proteins, by high-salt treatment of B. abortus (10, 12, 13) . We have shown here that the two proteins are, in fact, the same by molecular mass, antigenic cross-reactivity and N-terminal amino acid sequence. On the basis of amino acid sequence, the exact molecular weight of the recombinant E. coli-derived protein, and therefore by implication the Brucella-derived protein, is 16,071 (1). The identity of the sequenced recombinant E. coli-derived protein as Cu-Zn SOD was confirmed by assaying for enzymatic activity, resulting in a specific activity of 130 U/mg (1) (8) .
We observed some variability in the reaction of the SOD protein in the Western blot. It is likely that conformational changes are responsible for the loss of epitopes. An example of this is the reduction of SOD with 2-ME prior to Western blotting, which results in diminished antibody binding (B. J. Bricker, unpublished observations). Furthermore, when the gel was overloaded, multimeric forms of SOD were demonstrated by Western blot when electrophoresis was performed under nonreducing conditions (Fig. 4, lane C) . When the same sample was then treated with 2-ME, only one band at 20 kDa was observed, approximately 5 kDa larger than the smallest protein band under nonreducing conditions (data not shown; for comparison, see Fig. 4 , lanes B and C). Since these apparent multimers dissociate when SDS-PAGE is performed under reducing conditions, it is probable that polymerization occurs through disulfide interchange or aggregation. Western blots of whole-cell lysates of B. abortus and recombinant E. coli cells expressing the Cu-Zn SOD exhibited similar multimers (data not shown).
The advantage of studying the cloned gene products obtained from recombinant E. coli is that the protein is free from other Brucella proteins as well as Brucella lipopolysaccharide. This enabled us to produce polyclonal antiserum which was specific for a single Brucella antigen. By using this antiserum, a Western blot of Brucella lysates demonstrated unequivocally that Cu-Zn SOD occurs throughout most Brucella strains and species, with the possible exception of B. neotomae and B. suis biovar 2. Interestingly, Y. entercolitica appeared to express a cross-reacting protein of similar size and a second protein of higher molecular mass. Y. enterocolitica is known to have epitopes on its lipopolysaccharide which cross-react with Brucella lipopolysaccharide epitopes (4), but cross-reactivity between proteins has not been reported. It is unknown whether sera from Yersinia-infected animals will react with the Brucella Cu-Zn SOD. However, this may not pose a problem for diagnosis since Y. enterocolitica rarely infects cattle.
Since Cu-Zn SOD-free strains may exist in nature (B. 
